Correlation Between Gain Therapeutics and Galecto

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Gain Therapeutics and Galecto at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gain Therapeutics and Galecto into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gain Therapeutics and Galecto, you can compare the effects of market volatilities on Gain Therapeutics and Galecto and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gain Therapeutics with a short position of Galecto. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gain Therapeutics and Galecto.

Diversification Opportunities for Gain Therapeutics and Galecto

0.2
  Correlation Coefficient

Modest diversification

The 3 months correlation between Gain and Galecto is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Gain Therapeutics and Galecto in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Galecto and Gain Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gain Therapeutics are associated (or correlated) with Galecto. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Galecto has no effect on the direction of Gain Therapeutics i.e., Gain Therapeutics and Galecto go up and down completely randomly.

Pair Corralation between Gain Therapeutics and Galecto

Given the investment horizon of 90 days Gain Therapeutics is expected to generate 0.6 times more return on investment than Galecto. However, Gain Therapeutics is 1.68 times less risky than Galecto. It trades about 0.0 of its potential returns per unit of risk. Galecto is currently generating about -0.01 per unit of risk. If you would invest  218.00  in Gain Therapeutics on December 28, 2024 and sell it today you would lose (21.00) from holding Gain Therapeutics or give up 9.63% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy98.36%
ValuesDaily Returns

Gain Therapeutics  vs.  Galecto

 Performance 
       Timeline  
Gain Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Gain Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Gain Therapeutics is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.
Galecto 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Galecto has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Gain Therapeutics and Galecto Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Gain Therapeutics and Galecto

The main advantage of trading using opposite Gain Therapeutics and Galecto positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gain Therapeutics position performs unexpectedly, Galecto can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Galecto will offset losses from the drop in Galecto's long position.
The idea behind Gain Therapeutics and Galecto pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.